TRES CANTOS OPEN LAB FOUNDATION - Profile & Financials

Accounts Submitted 15 Sept 2025

Confirmation Statement Submitted 5 Jul 2025

Net assets £2.08M £803.93K 2024 year on year

Total assets £6.31M £1.30M 2024 year on year

Total Liabilities £4.23M £497.12K 2024 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Third Floor One London Square Cross Lanes Guildford Surrey GU1 1UN

Credit Report

Discover TRES CANTOS OPEN LAB FOUNDATION's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£6.26M

Decreased by £1.23M (-16%)

Net Assets

£2.08M

Decreased by £803.93k (-28%)

Total Liabilities

£4.23M

Decreased by £497.12k (-11%)

Turnover

£951.59k

Increased by £214.95k (+29%)

Employees

N/A

Debt Ratio

67%

Increased by 5 (+8%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

5 active 8 resigned

Show resigned officers

						Status
Alan Hutchinson Fairlamb	Director	British	United Kingdom	78	20 Nov 2014	Active
Carl Francis Nathan	Director	American	United States	79	10 Nov 2016	Active
Kenneth Duncan	Director	British	United States	67	15 May 2022	Active
Steven Sheldon	Director	British	United Kingdom	48	1 Apr 2024	Active
Valerie Mizrahi	Director	Italian	South Africa	67	8 Oct 2024	Active

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Glaxo Group Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

GLAXO GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE FINANCE PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GSK PLC united kingdom

TRES CANTOS OPEN LAB FOUNDATION Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
15 Sept 2025	Accounts	Annual accounts made up to 2024-12-31	View(26 pages)
5 Jul 2025	Confirmation Statement	Confirmation statement made on 2025-06-22 with no updates	View(3 pages)
4 Jul 2025	Persons With Significant Control	Change to Glaxo Group Limited as a person with significant control on 2023-06-06	View(2 pages)
16 Apr 2025	Officers	Appointment of Valerie Mizrahi as director on 2024-10-08	View(2 pages)
29 Jul 2024	Accounts	Annual accounts made up to 2023-12-31	View(26 pages)